Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Zuanji Liang"'
Autor:
Zhifeng Cen, Junlei Li, Hao Hu, Ka Cheng Lei, Cheng I Loi, Zuanji Liang, Tek Fai Chan, Carolina Oi Lam Ung
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
BackgroundThe “Specialist Medical Outreach Project (SMOP)” involving inter-disciplinary hospital-based healthcare professionals is a government initiative that aims to provide integrative specialist care to high-risk residents at the nursing home
Externí odkaz:
https://doaj.org/article/bf6012048b0a4423a2f823a0ece22e31
Publikováno v:
Chinese Medicine, Vol 16, Iss 1, Pp 1-16 (2021)
Abstract Background The National Medical Products Administration (NMPA) in China has set to advance the regulatory capacity of traditional Chinese medicines (TCMs) with the adoption of regulatory science (RS). However, the priority of actions at the
Externí odkaz:
https://doaj.org/article/f83c8873ced44c1487d7a057f379e912
Publikováno v:
Chinese Medicine, Vol 16, Iss 1, Pp 1-38 (2021)
Abstract Background Non-alcoholic fatty liver disease (NAFLD) is a common liver disease that may progress into, in the absence of proper treatment, severe liver damage. While the optimal pharmacotherapy for NAFLD remains uncertain and the adherence t
Externí odkaz:
https://doaj.org/article/1dc8c47b6ed044c7a9b7f20bde7c27f8
Autor:
Junnan Shi, Hao Hu, Joanna Harnett, Xiaoting Zheng, Zuanji Liang, Yi-Tao Wang, Carolina Oi Lam Ung
Publikováno v:
Chinese Medicine, Vol 14, Iss 1, Pp 1-20 (2019)
Abstract Background Nutraceuticals containing traditional Chinese medicine (TCM) are promoted for use in the management of diabetes. The evidence to support such use is largely unknown. This study aimed to summarise and evaluate the literature report
Externí odkaz:
https://doaj.org/article/00dc9be4e7b8490b916abdb3fc2ede18
Autor:
Meng Li, Shengqi Chen, Yunfeng Lai, Zuanji Liang, Jiaqi Wang, Junnan Shi, Haojie Lin, Dongning Yao, Hao Hu, Carolina Oi Lam Ung
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Real world evidence (RWE) and real-world data (RWD) are drawing ever-increasing attention in the pharmaceutical industry and drug regulatory authorities (DRAs) all over the world due to their paramount role in supporting drug development and regulato
Externí odkaz:
https://doaj.org/article/b36904b86c334aeead25a406788c95eb
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
Evidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
Background. An appropriate regulatory system to ensure and promote the quality, safety, and efficacy of the products of traditional medicine (TM) and complementary medicine (CM) is critical to not only public health but also economic growth. The regu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b035602e0c91b958274d35c692aa8ea2
https://doi.org/10.1155/2021/5833945
https://doi.org/10.1155/2021/5833945
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
Evidence-Based Complementary and Alternative Medicine, Vol 2021 (2021)
Background. Rhodiola is a worldwide used medicinal plant for its various medicinal functions, and the number of randomized controlled trials (RCTs) of Rhodiola is increasing in recent years. This study aims to evaluate the reporting quality and risk
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::70a92659f60903e65a9fbc0022b3dfff
https://doi.org/10.1155/2021/9989546
https://doi.org/10.1155/2021/9989546
Publikováno v:
Chinese Medicine, Vol 16, Iss 1, Pp 1-38 (2021)
Chinese Medicine
Chinese Medicine
Background Non-alcoholic fatty liver disease (NAFLD) is a common liver disease that may progress into, in the absence of proper treatment, severe liver damage. While the optimal pharmacotherapy for NAFLD remains uncertain and the adherence to lifesty
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cf60612385bf6cd76a380c47201687ab
https://doaj.org/article/1dc8c47b6ed044c7a9b7f20bde7c27f8
https://doaj.org/article/1dc8c47b6ed044c7a9b7f20bde7c27f8
Publikováno v:
Chinese Medicine
Chinese Medicine, Vol 16, Iss 1, Pp 1-16 (2021)
Chinese Medicine, Vol 16, Iss 1, Pp 1-16 (2021)
Background The National Medical Products Administration (NMPA) in China has set to advance the regulatory capacity of traditional Chinese medicines (TCMs) with the adoption of regulatory science (RS). However, the priority of actions at the interface
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c55aeed06d036f424076496f533209e
http://europepmc.org/articles/PMC7884970
http://europepmc.org/articles/PMC7884970
Autor:
Zuanji Liang, Junnan Shi, J. Wang, Yunfeng Lai, Meng Li, H. Lin, L.C. Ieong, Carolina Oi Lam Ung, Hao Hu
Publikováno v:
Value in Health Regional Issues. 22:S59
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::02392f6b368546cde7c85c5daf73a11f
https://doi.org/10.1016/j.vhri.2020.07.313
https://doi.org/10.1016/j.vhri.2020.07.313